Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
Crossref DOI link: https://doi.org/10.1186/s12872-017-0591-5
Published Online: 2017-06-17
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Halcox, Julian P.
Banegas, José R.
Roy, Carine
Dallongeville, Jean
De Backer, Guy
Guallar, Eliseo
Perk, Joep
Hajage, David
Henriksson, Karin M.
Borghi, Claudio
Funding for this research was provided by:
AstraZeneca